Author

Jodi D. Bradley

Observed names: J D Bradley, J.D. Bradley, Jodi Bradley, Jodi D Bradley

Observed institutions: DuPont (United States), University of Chicago, Bristol-Myers Squibb (United States), Scripps Whittier Diabetes Institute, Incyte (United States)

OpenAlex ID: A5019656644

Presenilin-1 and -2 Are Molecular Targets for γ-Secretase Inhibitors

2000 · Dietmar Seiffert, Jodi D. Bradley, et al. · Journal of Biological Chemistry · 301

Multivalent Ligand-Receptor Binding Interactions in the Fibroblast Growth Factor System Produce a Cooperative Growth Factor and Heparin Mechanism for Receptor Dimerization

1994 · Michael W. Pantoliano, Robert A. Horlick, et al. · Biochemistry · 238

Identification of ADAM10 as a major source of HER2 ectodomain sheddase activity in HER2 overexpressing breast cancer cells

2006 · Phillip C.C. Liu, Xiangdong Liu, et al. · Cancer Biology & Therapy · 198

High-level expression and purification of secreted forms of herpes simplex virus type 1 glycoprotein gD synthesized by baculovirus-infected insect cells

1994 · W P Sisk, J D Bradley, et al. · Journal of Virology · 113

Ionizing radiation improves survival in mice bearing intracranial high-grade gliomas injected with genetically modified herpes simplex virus.

1999 · J D Bradley, Y Kataoka, et al. · PubMed · 94

Expression and processing of biologically active fibroblast growth factors in the yeast Saccharomyces cerevisiae.

1988 · P J Barr, L S Cousens, et al. · Journal of Biological Chemistry · 80

Evidence that thrombocytopenia observed in humans treated with orally bioavailable glycoprotein IIb/IIIa antagonists is immune mediated

2002 · Jeffrey T. Billheimer, Ira B. Dicker, et al. · Blood · 60

Differential effects of heparin, fibronectin, and laminin on the phosphorylation of basic fibroblast growth factor by protein kinase C and the catalytic subunit of protein kinase A.

1989 · J J Feige, J D Bradley, et al. · The Journal of Cell Biology · 54

Mutations at the P1′ position of Notch1 decrease intracellular domain stability rather than cleavage by γ-secretase

2002 · Yuval Blat, Jere E Meredith, et al. · Biochemical and Biophysical Research Communications · 16

Deletion of hydrophobic domains of viral glycoproteins increases the level of their production in Escherichia coli

1992 · William P. Sisk, Jodi D. Bradley, et al. · Gene · 15

Efficacy of DAN-222, a novel investigational polymeric nanoparticle with topoisomerase I inhibitor, as monotherapy in breast cancer models and when combined with PARP inhibitor.

2021 · Ashley P Wright, Jodi D Bradley, et al. · Journal of Clinical Oncology · 4

Effects of the glycoprotein IIb/IIIa antagonist Roxifiban on P-selectin expression, fibrinogen binding, and microaggregate formation in a phase I dose-finding study: no evidence for platelet activation during treatment with a glycoprotein IIb/IIIa antagonist

2003 · Dietmar Seiffert, Beth E. Thomas, et al. · Platelets · 4

Abstract P2-13-09: An investigational next generation ADC (DAN-311) is highly effective in HER2-low breast cancer models

2022 · Ashley P Wright, Emily A Wyatt, et al. · Cancer Research · 3

P3‐288: Gamma‐secretase inhibitors have intrinsically different potencies against Aβ production and Notch signaling

2010 · Catherine R. Burton, Jere E. Meredith, et al. · Alzheimer s & Dementia

2042 A novel therapeutic approach for hepatocellular carcinoma using replication-competent herpes simplex virus and ionizing radiation

1999 · S. Chung, S.J. Advani, et al. · International Journal of Radiation Oncology*Biology*Physics

Works count: 15

Citation count: 1,180

H-index: 10

I10-index: 10